Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | COVID-19 | Research

Predictors of bacteremia and death, including immune status, in a large single-center cohort of unvaccinated ICU patients with COVID-19 pneumonia

Authors: Antonella Frattari, Ennio Polilli, Giorgia Rapacchiale, Simona Coladonato, Stefano Ianniruberto, Elena Mazzotta, Alessandro Patarchi, Mariangela Battilana, Raffaella Ciulli, Angelo Moretta, Lina Visocchi, Vincenzo Savini, Antonella Spacone, Rosamaria Zocaro, Fabrizio Carinci, Giustino Parruti

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

We investigated the possible role of the immune profile at ICU admission, among other well characterized clinical and laboratory predictors of unfavorable outcome in COVID-19 patients assisted in ICU.

Methods

Retrospective analysis of clinical and laboratory data collected for all consecutive patients admitted to the ICUs of the General Hospital of Pescara (Abruzzo, Italy), between 1st March 2020 and 30th April 2021, with a confirmed diagnosis of COVID-19 respiratory failure. Logistic regressions were used to identify independent predictors of bacteremia and mortality.

Results

Out of 431 patients included in the study, bacteremia was present in N = 191 (44.3%) and death occurred in N = 210 (48.7%). After multivariate analysis, increased risk of bacteremia was found for viral reactivation (OR = 3.28; 95% CI:1.83–6.08), pronation (3.36; 2.12–5.37) and orotracheal intubation (2.51; 1.58–4.02). Increased mortality was found for bacteremia (2.05; 1.31–3.22), viral reactivation (2.29; 1.29–4.19) and lymphocytes < 0.6 × 103c/µL (2.32; 1.49–3.64).

Conclusions

We found that viral reactivation, mostly due to Herpesviridae, was associated with increased risk of both bacteremia and mortality. In addition, pronation and intubation are strong predictors of bacteremia, which in turn together with severe lymphocytopenia due to SARS-CoV2 was associated with increased mortality. Most episodes of bacteremia, even due to Acinetobacter spp, were not predicted by microbiological evidence of colonization.
Literature
1.
go back to reference De Waele JJ, Schouten J, Beovic B, Tabah A, Leone M. Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of experts. Intensive Care Med. 2020;46:236–44.CrossRefPubMedPubMedCentral De Waele JJ, Schouten J, Beovic B, Tabah A, Leone M. Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of experts. Intensive Care Med. 2020;46:236–44.CrossRefPubMedPubMedCentral
2.
go back to reference Frattari A, Savini V, Polilli E, Di Marco G, Lucisano G, Corridoni S, et al. Control of Gram-negative multidrug-resistant microorganisms in an Italian ICU: Rapid decline as a result of a multifaceted intervention, including conservative use of antibiotics. Int J Infect Dis. 2019;84:153–62.CrossRefPubMed Frattari A, Savini V, Polilli E, Di Marco G, Lucisano G, Corridoni S, et al. Control of Gram-negative multidrug-resistant microorganisms in an Italian ICU: Rapid decline as a result of a multifaceted intervention, including conservative use of antibiotics. Int J Infect Dis. 2019;84:153–62.CrossRefPubMed
3.
go back to reference Landelle C, Marimuthu K, Harbarth S. Infection control measures to decrease the burden of antimicrobial resistance in the critical care setting. Curr Opin Crit Care. 2014;20:499–506.CrossRefPubMed Landelle C, Marimuthu K, Harbarth S. Infection control measures to decrease the burden of antimicrobial resistance in the critical care setting. Curr Opin Crit Care. 2014;20:499–506.CrossRefPubMed
4.
go back to reference Mazzeffi M, Galvagno S, Rock C. Prevention of healthcare-associated infections in intensive care unit patients. Anesthesiology. 2021;135:1122–31.CrossRefPubMed Mazzeffi M, Galvagno S, Rock C. Prevention of healthcare-associated infections in intensive care unit patients. Anesthesiology. 2021;135:1122–31.CrossRefPubMed
5.
go back to reference Sligl WI, Dragan T, Smith SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Infect Dis. 2015;37:129–34.CrossRefPubMed Sligl WI, Dragan T, Smith SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Infect Dis. 2015;37:129–34.CrossRefPubMed
6.
go back to reference Bassetti M, Kollef MH, Timsit J-F. Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive Care Med. 2020;46:2071–4.CrossRefPubMedPubMedCentral Bassetti M, Kollef MH, Timsit J-F. Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive Care Med. 2020;46:2071–4.CrossRefPubMedPubMedCentral
7.
go back to reference Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, et al. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network. Intensive Care Med. 2021;47:180–7.CrossRefPubMedPubMedCentral Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, et al. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network. Intensive Care Med. 2021;47:180–7.CrossRefPubMedPubMedCentral
8.
go back to reference Kokkoris S, Papachatzakis I, Gavrielatou E, Ntaidou T, Ischaki E, Malachias S, et al. ICU-acquired bloodstream infections in critically ill patients with COVID-19. J Hosp Infect. 2021;107:95–7.CrossRefPubMed Kokkoris S, Papachatzakis I, Gavrielatou E, Ntaidou T, Ischaki E, Malachias S, et al. ICU-acquired bloodstream infections in critically ill patients with COVID-19. J Hosp Infect. 2021;107:95–7.CrossRefPubMed
9.
go back to reference Timsit J-F, Ruppé E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46:266–84.CrossRefPubMedPubMedCentral Timsit J-F, Ruppé E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46:266–84.CrossRefPubMedPubMedCentral
10.
go back to reference Aslan A, Aslan C, Zolbanin NM, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia (Nathan). 2021;13:14.CrossRefPubMed Aslan A, Aslan C, Zolbanin NM, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia (Nathan). 2021;13:14.CrossRefPubMed
11.
go back to reference Hajjar LA, da Costa IBS, Rizk SI, Biselli B, Gomes BR, Bittar CS, et al. Intensive care management of patients with COVID-19: a practical approach. Ann Intensive Care. 2021;11:36.CrossRefPubMedPubMedCentral Hajjar LA, da Costa IBS, Rizk SI, Biselli B, Gomes BR, Bittar CS, et al. Intensive care management of patients with COVID-19: a practical approach. Ann Intensive Care. 2021;11:36.CrossRefPubMedPubMedCentral
12.
go back to reference Giacobbe DR, Battaglini D, Enrile EM, Dentone C, Vena A, Robba C, et al. Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with COVID-19: a multicenter study. J Clin Med. 2021;10:555.CrossRefPubMedPubMedCentral Giacobbe DR, Battaglini D, Enrile EM, Dentone C, Vena A, Robba C, et al. Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with COVID-19: a multicenter study. J Clin Med. 2021;10:555.CrossRefPubMedPubMedCentral
13.
go back to reference Ippolito M, Simone B, Filisina C, Catalanotto FR, Catalisano G, Marino C, et al. Bloodstream infections in hospitalized patients with COVID-19: a systematic review and meta-analysis. Microorganisms. 2021;9:2016.CrossRefPubMedPubMedCentral Ippolito M, Simone B, Filisina C, Catalanotto FR, Catalisano G, Marino C, et al. Bloodstream infections in hospitalized patients with COVID-19: a systematic review and meta-analysis. Microorganisms. 2021;9:2016.CrossRefPubMedPubMedCentral
14.
go back to reference Textoris J, Mallet F. Immunosuppression and herpes viral reactivation in intensive care unit patients: one size does not fit all. Crit Care. 2017;21:230.CrossRefPubMedPubMedCentral Textoris J, Mallet F. Immunosuppression and herpes viral reactivation in intensive care unit patients: one size does not fit all. Crit Care. 2017;21:230.CrossRefPubMedPubMedCentral
15.
go back to reference Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.CrossRefPubMed Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.CrossRefPubMed
19.
go back to reference Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31:1–10.CrossRefPubMed Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31:1–10.CrossRefPubMed
20.
go back to reference Dautzenberg MJD, Wekesa AN, Gniadkowski M, Antoniadou A, Giamarellou H, Petrikkos GL, et al. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med. 2015;43:1170–7.CrossRefPubMedPubMedCentral Dautzenberg MJD, Wekesa AN, Gniadkowski M, Antoniadou A, Giamarellou H, Petrikkos GL, et al. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med. 2015;43:1170–7.CrossRefPubMedPubMedCentral
21.
go back to reference Cantenys-Molina S, Fernández-Cruz E, Francos P, Lopez Bernaldo de Quirós JC, Muñoz P, Gil-Herrera J. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain. Clin Exp Immunol. 2021;203:424–32. Cantenys-Molina S, Fernández-Cruz E, Francos P, Lopez Bernaldo de Quirós JC, Muñoz P, Gil-Herrera J. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain. Clin Exp Immunol. 2021;203:424–32.
22.
go back to reference Frattari A, Polilli E, Primiterra V, Savini V, Ursini T, Di Iorio G, et al. Analysis of peripheral blood lymphocyte subsets in critical patients at ICU admission: a preliminary investigation of their role in the prediction of sepsis during ICU stay. Int J Immunopathol Pharmacol. 2018;32:2058738418792310.CrossRefPubMedPubMedCentral Frattari A, Polilli E, Primiterra V, Savini V, Ursini T, Di Iorio G, et al. Analysis of peripheral blood lymphocyte subsets in critical patients at ICU admission: a preliminary investigation of their role in the prediction of sepsis during ICU stay. Int J Immunopathol Pharmacol. 2018;32:2058738418792310.CrossRefPubMedPubMedCentral
23.
go back to reference Polilli E, Esposito JE, Frattari A, Trave F, Sozio F, Ferrandu G, et al. Circulating lymphocyte subsets as promising biomarkers to identify septic patients at higher risk of unfavorable outcome. BMC Infect Dis. 2021;21:780.CrossRefPubMedPubMedCentral Polilli E, Esposito JE, Frattari A, Trave F, Sozio F, Ferrandu G, et al. Circulating lymphocyte subsets as promising biomarkers to identify septic patients at higher risk of unfavorable outcome. BMC Infect Dis. 2021;21:780.CrossRefPubMedPubMedCentral
24.
go back to reference Hatayama Y, Hashimoto Y, Motokura T. Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapy. J Int Med Res. 2020;48:300060520972880.CrossRefPubMed Hatayama Y, Hashimoto Y, Motokura T. Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapy. J Int Med Res. 2020;48:300060520972880.CrossRefPubMed
25.
go back to reference Yiang G-T, Tzeng I-S, Shui H-A, Wu M-Y, Peng M-Y, Chan C-Y, et al. Early screening of risk for multidrug-resistant organisms in the emergency department in patients with pneumonia and early septic shock: single-center. Retrospective Cohort Study Shock. 2021;55:198–209.PubMed Yiang G-T, Tzeng I-S, Shui H-A, Wu M-Y, Peng M-Y, Chan C-Y, et al. Early screening of risk for multidrug-resistant organisms in the emergency department in patients with pneumonia and early septic shock: single-center. Retrospective Cohort Study Shock. 2021;55:198–209.PubMed
26.
go back to reference Bogossian EG, Taccone FS, Izzi A, Yin N, Garufi A, Hublet S, et al. The acquisition of multidrug-resistant bacteria in patients admitted to COVID-19 intensive care units: a monocentric retrospective case control study. Microorganisms. 2020;8:E1821.CrossRef Bogossian EG, Taccone FS, Izzi A, Yin N, Garufi A, Hublet S, et al. The acquisition of multidrug-resistant bacteria in patients admitted to COVID-19 intensive care units: a monocentric retrospective case control study. Microorganisms. 2020;8:E1821.CrossRef
27.
go back to reference Sun Jin L, Fisher D. MDRO transmission in acute hospitals during the COVID-19 pandemic. Curr Opin Infect Dis. 2021;34:365–71.CrossRefPubMed Sun Jin L, Fisher D. MDRO transmission in acute hospitals during the COVID-19 pandemic. Curr Opin Infect Dis. 2021;34:365–71.CrossRefPubMed
28.
go back to reference Langford BJ, So M, Raybardhan S, Leung V, Soucy JPR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27:520–31.CrossRefPubMedPubMedCentral Langford BJ, So M, Raybardhan S, Leung V, Soucy JPR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27:520–31.CrossRefPubMedPubMedCentral
29.
go back to reference Mascitti H, Duran C, Nemo E-M, Bouchand F, Câlin R, Descatha A, et al. Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study. Antimicrob Resist Infect Control. 2018;7:116.CrossRefPubMedPubMedCentral Mascitti H, Duran C, Nemo E-M, Bouchand F, Câlin R, Descatha A, et al. Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study. Antimicrob Resist Infect Control. 2018;7:116.CrossRefPubMedPubMedCentral
30.
go back to reference Oliva A, Miele MC, Di Timoteo F, De Angelis M, Mauro V, Aronica R, et al. Persistent systemic microbial translocation and intestinal damage during coronavirus disease-19. Front Immunol. 2021;12: 708149.CrossRefPubMedPubMedCentral Oliva A, Miele MC, Di Timoteo F, De Angelis M, Mauro V, Aronica R, et al. Persistent systemic microbial translocation and intestinal damage during coronavirus disease-19. Front Immunol. 2021;12: 708149.CrossRefPubMedPubMedCentral
31.
go back to reference Wu X, Jing H, Wang C, Wang Y, Zuo N, Jiang T, et al. Intestinal damage in COVID-19: SARS-CoV-2 infection and intestinal thrombosis. Front Microbiol. 2022;13: 860931.CrossRefPubMedPubMedCentral Wu X, Jing H, Wang C, Wang Y, Zuo N, Jiang T, et al. Intestinal damage in COVID-19: SARS-CoV-2 infection and intestinal thrombosis. Front Microbiol. 2022;13: 860931.CrossRefPubMedPubMedCentral
32.
go back to reference Phua J, Weng L, Ling L, Egi M, Lim C-M, Divatia JV, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8:506–17.CrossRefPubMedPubMedCentral Phua J, Weng L, Ling L, Egi M, Lim C-M, Divatia JV, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8:506–17.CrossRefPubMedPubMedCentral
33.
go back to reference Lee PI, Ciccone EJ, Read SW, Asher A, Pitts R, Douek DC, et al. Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. J Infect Dis. 2009;199:1664–70.CrossRefPubMed Lee PI, Ciccone EJ, Read SW, Asher A, Pitts R, Douek DC, et al. Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. J Infect Dis. 2009;199:1664–70.CrossRefPubMed
34.
go back to reference Gatto I, Biagioni E, Coloretti I, Farinelli C, Avoni C, Caciagli V, et al. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. Intensive Care Med. 2022;48:706–13.CrossRefPubMedPubMedCentral Gatto I, Biagioni E, Coloretti I, Farinelli C, Avoni C, Caciagli V, et al. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. Intensive Care Med. 2022;48:706–13.CrossRefPubMedPubMedCentral
Metadata
Title
Predictors of bacteremia and death, including immune status, in a large single-center cohort of unvaccinated ICU patients with COVID-19 pneumonia
Authors
Antonella Frattari
Ennio Polilli
Giorgia Rapacchiale
Simona Coladonato
Stefano Ianniruberto
Elena Mazzotta
Alessandro Patarchi
Mariangela Battilana
Raffaella Ciulli
Angelo Moretta
Lina Visocchi
Vincenzo Savini
Antonella Spacone
Rosamaria Zocaro
Fabrizio Carinci
Giustino Parruti
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01166-8

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue